CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04834934
NCT04834934N/ACompleted

Artificial Intelligence - SARS-CoV-2 Risk Evaluation

IRCCS San Raffaele·observational·Posted Apr 8, 2021·Updated May 1, 2025

In Brief

An observational study for Covid19. Completed, enrolled 2,000 participants across 1 site.

Detailed Summary

The management of COVID-19 patients in overwhelmed hospital facing the pandemic is a clinical challenge. The improvement of decision making may allow a better allocation of available resources and a better treatment of patients at higher risk. Chest CT has been widely adopted for COVID-19 pneumonia diagnosis. Several experiences documented the capability of Artificial Intelligence to improve and fasten COVID-19 pneumonia detection, mainly using chest X-ray. Aim of the present study was to develop and validate an Artificial Intelligence approach integrating clinical and imaging data (automatically extracted through the adoption of dedicated neural networks) for the creation of a cloud platform capable of performing automatic patients risk stratification. Such an approach could be used for triage of COVID-19 patients in the emergency department, with the aim to improve healthcare personnel decision-making and allocation of resources during health emergencies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesItaly

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedApr 8, 2021
Enrollment StartFeb 16, 2020
Primary CompletionSep 30, 2020
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.2 years ago